Email
IZ Express #1,687: Check for current versions of COVID-19 vaccine guidance and tools, and more
| From | Immunize.org <[email protected]> |
| Subject | IZ Express #1,687: Check for current versions of COVID-19 vaccine guidance and tools, and more |
| Date | April 12, 2023 10:01 AM |
Links have been removed from this email. Learn more in the FAQ.
Links have been removed from this email. Learn more in the FAQ.
[link removed]
[link removed]
[link removed]
[link removed] [link removed]
Email not displaying correctly? View it in your browser ([link removed]).
[link removed]
Issue 1,687: April 12, 2023
Top Stories
* Immunize.org updates its "Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools"
* Celebrate National Adult Hepatitis B Vaccination Awareness Day, April 30, with the Hepatitis B Foundation’s resources and social media toolkit
* National Infant Immunization Week is April 24–30; use CDC’s digital media toolkit
* April is National Minority Health Month; Immunize.org supports better health through better understanding with our broad array of translated materials
* Spotlight: Immunize.org's "Handouts" main page provides free access to hundreds of vaccination-related handouts and fact sheets
* Vaccines in the news
Immunize.org Pages and Handouts
* Immunize.org updates “Administering Vaccines: Dose, Route, Site, and Needle Size” print-ready documents
* Immunize.org updates two documents for healthcare providers on injecting intramuscular and subcutaneous vaccines
* Immunize.org updates parent handout titled “Top Ten Reasons to Protect Your Child by Vaccinating”
* Immunize.org updates “Talking about Vaccines: Religious Concerns” web page
* Immunize.org updates its “Vaccine Timeline” web page
Featured Resources
* Improve uptake of HPV vaccine with the Society for Women's Health Research social media toolkit
* NFID posts new podcast episode featuring Julie L. Gerberding, MD, MPH, on breaking the cycle of crisis to complacency
* While supplies last! Laminated versions of CDC’s 2023 immunization schedules now shipping.
Notable Publications
* “Widespread Community Transmission of Hepatitis A following an Outbreak at a Local Restaurant—Virginia, September 2021–September 2022” published in MMWR
* “Seasonality of Respiratory Syncytial Virus—United States, 2017–2023” published in MMWR
Global News
* “Update on Vaccine-Derived Poliovirus Outbreaks Worldwide—January 2021–December 2022” published in MMWR
Upcoming Events
* Virtual: NFID hosts “2023 Annual Conference on Vaccinology Research” on June 5–7; registration is open; CME available
------------------------------------------------------------
Top Stories
------------------------------------------------------------
Immunize.org updates its "Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools"
Immunize.org reviews and updates the Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) every month, prominently indicating when it was last updated at the top of the page. This month’s update reflects CDC’s new recommendation for booster doses for children age 6 months through 4 years who received Pfizer-BioNTech monovalent vaccines as the 3-dose primary series. Children in this age group who received a Pfizer-BioNTech bivalent vaccine as the third dose of the primary series are still not recommended to receive a booster dose.
All COVID-19 vaccination providers should review the checklist regularly. The checklist is posted on Immunize.org's Vaccines: COVID-19 ([link removed]) main page, to help practices stay up to date.
Related Links
* Immunize.org: Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) (PDF)
* Immunize.org: Vaccines: COVID-19 ([link removed]) main page
* Immunize.org: Ask the Experts: COVID-19 ([link removed]) web page
* CDC: Interim Clinical Considerations ([link removed]) main page summarizing use of COVID-19 vaccines in the United States
------------------------------------------------------------
Celebrate National Adult Hepatitis B Vaccination Awareness Day, April 30, with the Hepatitis B Foundation’s resources and social media toolkit
Anyone can be infected with hepatitis B and all adults can benefit from knowing their status and being protected. April 30 is National Adult Hepatitis B Vaccination Awareness Day ([link removed])—a great time to make sure your patients know they need to be protected from the world's leading cause of liver cancer. The hepatitis B vaccine is now routinely recommended for adults age 19–59, yet 70% of adults have not completed the series. Adults age 60 and older also may be vaccinated.
The Hepatitis B Foundation ([link removed]) offers a social media toolkit ([link removed]) featuring graphics and sample posts. The toolkit includes a Call to Action ([link removed]) to eliminate hepatitis B through universal adult hepatitis B screening and vaccination.
Related Links
* CDC: Viral Hepatitis ([link removed]) web page
* Hepatitis B Foundation: National Adult Hepatitis B Vaccination Awareness 2023 ([link removed]) resources
* Immunize.org: Vaccines: Hepatitis B ([link removed]) main page
------------------------------------------------------------
National Infant Immunization Week is April 24–30; use CDC’s digital media toolkit
National Infant Immunization Week ([link removed]) (NIIW), April 24–30, highlights the importance of protecting infants from vaccine-preventable diseases and celebrates the achievements of immunization partners. Completing the recommended vaccinations by age 2 years is the best way to protect young children from 15 potentially life-threatening diseases. After the disruptions of three pandemic years, these messages are more important than ever for families to hear.
CDC makes it simple for you to participate in NIIW by using their 2023 NIIW Digital Media Toolkit ([link removed]) to plan activities. The toolkit includes updated English and Spanish logos, sample social media content, social graphics, and key messages. Please share your posts using the hashtag #ivax2protect.
Related Links
* CDC: National Infant Immunization Week ([link removed]) main page
* CDC: 2023 NIIW Digital Media Toolkit ([link removed]) main page
* Immunize.org: Parent Handouts ([link removed]) main page
------------------------------------------------------------
April is National Minority Health Month; Immunize.org supports better health through better understanding with our broad array of translated materials
April is National Minority Health Month ([link removed]) , a time to focus on the importance of reducing health disparities. This year’s theme focuses on improving health outcomes for racial and ethnic minority and American Indian/Alaska Native (AI/AN) communities by providing them with culturally and linguistically competent healthcare services, information, and resources. When patients get this type of culturally appropriate support, they are empowered to create healthier outcomes for themselves and their communities.
Immunize.org is working with partners to increase the availability of linguistically appropriate Vaccine Information Statements (VISs). During February and March, VIS translations were posted in eight languages: Bengali ([link removed]), Dari ([link removed]), Haitian Creole ([link removed]), Hmong ([link removed]), Pashto ([link removed]), Portuguese ([link removed]), Thai ([link removed]), and Ukrainian ([link removed]).
Immunize.org also provides users with access to translations of some of our most popular vaccination-related handouts and fact sheets for healthcare professionals and the public. Translations of these are available in up to eight languages: Arabic ([link removed]), Chinese ([link removed]), French ([link removed]), Korean ([link removed]), Russian ([link removed]), Spanish ([link removed]), Turkish ([link removed]), and Vietnamese ([link removed]).
Related Links
* HHS: National Minority Health Month ([link removed]) web page
* Immunize.org: Vaccine Information Statement ([link removed]) main page for VISs in 47 languages
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
* Immunize.org: Educational Materials for Patients and Staff ([link removed])—an alphabetical listing of more than 230 ready-to-print staff educational materials and patient handouts
------------------------------------------------------------
Spotlight: Immunize.org's "Handouts" main page provides free access to hundreds of vaccination-related handouts and fact sheets
Immunize.org's Handouts for Patients and Staff ([link removed]) web page leads users to hundreds of free vaccination-related patient handouts and fact sheets for healthcare professionals. All items are ready to print, copy, and distribute widely.
Visit the Handouts for Patients and Staff ([link removed]) web page to view more than 230 handouts sorted by:
* Topic ([link removed])
* Vaccine ([link removed])
* Language ([link removed])
From the main page, you can search by any of the 22 topics. Some of the most popular are:
* Administering Vaccines ([link removed])
* Parent Handouts ([link removed])
* Screening Checklists ([link removed])
* Standing Orders ([link removed])
* Temperature Logs ([link removed])
* Top Handouts ([link removed])
The right-hand side of the web page includes links to some of Immunize.org's most popular handouts, including:
* Summary of Recommendations for Children and Teens ([link removed])
* Summary of Recommendations for Adults ([link removed])
* Vaccinations for Adults—You’re Never Too Old to Get Immunized ([link removed])
* When Do Children and Teens Need Vaccinations? ([link removed])
* How to Administer Intramuscular and Subcutaneous Vaccine Injections: Administration by the Intramuscular (IM) Route ([link removed])
You can also view an alphabetical listing of Immunize.org’s more than 230 ready-to-print staff educational materials and patient handouts ([link removed]).
Visit Immunize.org's Handouts for Patients and Staff ([link removed]) web page today!
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* Bloomberg Law: Future COVID Shots Need Broader Coverage, FDA Vaccine Head Says ([link removed]) (4/4/23)
* Scripps News: What Happens to COVID Vaccines When the Public Health Emergency Ends? ([link removed]) (4/3/23)
* Precision Vaccinations: Has Polio Returned to America ([link removed]) (4/3/23)
------------------------------------------------------------
Immunize.org Pages and Handouts
------------------------------------------------------------
Immunize.org updates “Administering Vaccines: Dose, Route, Site, and Needle Size” print-ready documents
Immunize.org recently updated two of its print-ready documents: Administering Vaccines: Dose, Route, Site, and Needle Size ([link removed]) and Administering Vaccines to Adults: Dose, Route, Site, and Needle Size ([link removed]) . The documents now reflect the recent FDA approval of intramuscular (IM) administration of Merck's measles-mumps-rubella vaccine (MMR, brand name M-M-R II), varicella (Varivax), and MMRV (ProQuad) vaccines as an alternative to subcutaneous (Subcut) administration. GSK’s MMR (Priorix) remains approved for Subcut administration only.
Related Links
* Immunize.org: Handouts: Administering Vaccines ([link removed]) main page
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
* Immunize.org: Educational Materials for Patients and Staff ([link removed])—an alphabetical listing of more than 230 ready-to-print staff educational materials and patient handouts
------------------------------------------------------------
Immunize.org updates two documents for healthcare providers on injecting intramuscular and subcutaneous vaccines
Immunize.org recently updated its How to Administer Intramuscular and Subcutaneous Vaccine Injections ([link removed]) handout and How to Administer Intramuscular and Subcutaneous Vaccine Injections to Adults ([link removed]) handout. Changes include:
* Intramuscular (IM) administration of Merck's MMR (M-M-R II), varicella (Varivax), and MMRV (ProQuad) vaccines as well as the current subcutaneous (Subcut) listing. GSK's MMR (Priorix) remains Subcut only.
* Grouping vaccines into categories of IM only, IM or Subcut, Subcut only, and Subcut or intradermal routes
Related Links
* Immunize.org: Handouts: Administering Vaccines ([link removed]) main page
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
* Immunize.org: Educational Materials for Patients and Staff ([link removed])—an alphabetical listing of more than 230 ready-to-print staff educational materials and patient handouts
------------------------------------------------------------
Immunize.org updates parent handout titled “Top Ten Reasons to Protect Your Child by Vaccinating”
Immunize.org recently updated its handout for parents titled Top Ten Reasons to Protect Your Child by Vaccinating ([link removed]). Minor changes were made to the text to enhance comprehension. A QR code in the footer now links to the online version of the document.
Related Links
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
* Immunize.org: Educational Materials for Patients and Staff ([link removed])—an alphabetical listing of more than 230 ready-to-print staff educational materials and patient handouts
------------------------------------------------------------
Immunize.org updates “Talking about Vaccines: Religious Concerns” web page
Immunize.org updated its Talking about Vaccines: Religious Concerns ([link removed]) main page. This page leads to many resources from Immunize.org, CDC, and others to help healthcare professionals communicate with parents and patients about important vaccine topics. Additions are described below.
* Added the Statement on COVID-19 Vaccines from the Orthodox Union and Rabbinical Council of America ([link removed]) from the Orthodox Union (OU) and the Rabbinical Council of America (RCA)
* Added Address Concerns About Religious Beliefs ([link removed]) from the American Pharmacists Association Vaccine Confident Initiative
Related Link
* Immunize.org: Talking about Vaccines ([link removed]) main page
------------------------------------------------------------
Immunize.org updates its “Vaccine Timeline” web page
Immunize.org's Vaccine Timeline ([link removed]) main page was updated on April 4 to include new events related to vaccines and immunization. The chart on the main page displays many of the vaccine- and immunization-related events since Edward Jenner's first smallpox vaccination in 1796. This list is by no means exhaustive.
If you would like to suggest an event to add, contact us at [email protected].
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
Improve uptake of HPV vaccine with the Society for Women's Health Research social media toolkit
April is Sexually Transmitted Infections Awareness Month. The Society for Women's Health Research (SWHR) offers resources to improve education ([link removed]) on human papillomavirus (HPV) vaccine and its crucial role in public health.
Check out the HPV Vaccine Social Media Toolkit ([link removed]) today and follow the HPV vaccine conversation at #SWHRtalksHPV and on all SWHR social channels.
------------------------------------------------------------
NFID posts new podcast episode featuring Julie L. Gerberding, MD, MPH, on breaking the cycle of crisis to complacency
Infectious IDeas ([link removed]), a podcast series from the National Foundation for Infectious Diseases (NFID), brings leading experts together for thought-provoking conversations that lead to infectious ideas. The latest entry in the series, Breaking the Cycle of Crisis to Complacency ([link removed]), features Julie L. Gerberding, MD, MPH. A description from the web page appears below.
As the first female director of the Centers for Disease Control and Prevention (CDC), Julie L. Gerberding, MD, MPH, led the agency through 40 public health crises, including SARS-CoV-1. As CEO of the Foundation for the National Institutes of Health, she now advocates for change to strengthen US health security and break the cycle of crisis to complacency.
------------------------------------------------------------
While supplies last! Laminated versions of CDC’s 2023 immunization schedules now shipping.
Immunize.org's laminated versions of the 2023 U.S. child and adolescent immunization schedule ([link removed]) and the 2023 U.S. adult immunization schedule ([link removed]) are in stock and shipping now. Order while supplies last. Once sold out, we will not print more until 2024.
While the schedules are available online from CDC at no cost, Immunize.org’s laminated schedules are ideal for use in any busy healthcare setting. Their tough coating can be wiped down, and they’re durable enough to stand up to a year of use.
* Length: Each schedule with appendices is 12 pages
* Size: Standard 8.5” X 11” booklet format
* Full Color: With color coding for easy reading, our laminated schedules replicate the original CDC formatting, including the essential tables and notes
* Bonus: The adult schedule includes Immunize.org’s popular 1-page handout summarizing the dose, route, and needle length recommendations for all vaccines and recipients
Pricing for Each Schedule
$10.00: 1 copy
$ 9.50 each: 2–4 copies
$ 8.50 each: 5–19 copies
$ 7.50 each: 20–99 copies
$ 6.00 each: 100–499 copies
$ 5.00 each: 500–999 copies
$ 4.00 each: 1,000–1,999 copies
$ 3.25 each: 2,000+ copies
Visit Shop Immunize.org: Laminated Schedules ([link removed]) to view images of each page and order today!
For additional information, call 651-647-9009 or email [email protected].
Related Links
* Immunize.org: Laminated Child and Adolescent Immunization Schedules (0–18 years) ([link removed]) web page
* Immunize.org: Laminated Adult Immunization Schedules (19 and older) ([link removed]) web page
* Immunize.org: Shop Immunize.org ([link removed]) main page
* CDC: Immunization Schedules ([link removed])
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
“Widespread Community Transmission of Hepatitis A following an Outbreak at a Local Restaurant—Virginia, September 2021–September 2022” published in MMWR
CDC published Widespread Community Transmission of Hepatitis A Virus following an Outbreak at a Local Restaurant—Virginia, September 2021–September 2022 ([link removed]) in the April 7 issue of MMWR ([link removed]). A portion of the summary appears below.
In 2021, a hepatitis A outbreak in Virginia traced to an unvaccinated food handler resulted in 51 cases, 31 hospitalizations, and three deaths. As of September 30, 2022, an additional 98 community hepatitis A cases had been reported in the Roanoke City and Alleghany Health Districts. . . .
Public health partnerships with businesses and other community partners (e.g., harm reduction programs) might increase hepatitis A vaccination among persons at risk for this infection, while also reducing the stigmatization of hepatitis A-associated risk factors.
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]) .
Related Link
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications
------------------------------------------------------------
“Seasonality of Respiratory Syncytial Virus—United States, 2017–2023” published in MMWR
CDC published Seasonality of Respiratory Syncytial Virus—United States, 2017–2023 ([link removed]) in the April 7 issue of MMWR ([link removed]).
The article explains that, nationally, prepandemic seasons (2017– 2020) began in October, peaked in December, and ended in April. During 2020–21, the typical winter RSV epidemic did not occur. The 2021–22 season began in May, peaked in July, and ended in January. The 2022–23 season started (June) and peaked (November) later than the 2021–22 season, but earlier than prepandemic seasons. In both prepandemic and pandemic periods, epidemics began earlier in Florida and the Southeast and later in regions further north and west.
With several RSV prevention products in development, ongoing monitoring of RSV circulation can guide the timing of RSV immunoprophylaxis and of clinical trials and postlicensure effectiveness studies. Although the timing of the 2022–23 season suggests that seasonal patterns are returning toward those observed in prepandemic years, clinicians should be aware that off-season RSV circulation might continue.
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]).
Related Link
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications
------------------------------------------------------------
Global News
------------------------------------------------------------
“Update on Vaccine-Derived Poliovirus Outbreaks Worldwide—January 2021–December 2022” published in MMWR
CDC published Update on Vaccine-Derived Poliovirus Outbreaks Worldwide—January 2021–December 2022 ([link removed]) in the April 7 issue of MMWR ([link removed]). A portion of the summary appears below.
During January 2021–December 2022, 76 [circulating vaccine-derived polioviruses] cVDPV type 2 outbreaks occurred in 42 countries. Since 2020, the numbers of paralytic cases and new emergences have declined following the introduction of a safer novel type 2 oral poliovirus vaccine for outbreak control. The number of cVDPV type 1 outbreaks increased during 2021–2022 as COVID-19 pandemic–associated global routine immunization coverage declined. . . .
Improving routine immunization coverage, strengthening poliovirus surveillance, and conducting timely and high-quality supplementary immunization activity responses to cVDPV outbreaks in 2023 are necessary to stop cVDPV transmission.
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]).
Related Link
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Virtual: NFID hosts “2023 Annual Conference on Vaccinology Research” on June 5–7; registration is open; CME available
The National Foundation for Infectious Diseases (NFID) will host its 2023 Annual Conference on Vaccinology Research ([link removed]) (ACVR) on June 5–7. Learn and network with hundreds of researchers and healthcare professionals from around the world. The conference will feature informative presentations with interactive audience discussions, peer-reviewed oral and poster abstracts, and an inspiring session spotlighting women leaders in vaccinology.
Registration is now open ([link removed]) and there is a $400 fee to attend. NFID will offer CME for the live activity. Visit the ACVR website ([link removed]) for updates and additional information.
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]).
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles. When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]).
IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer ([link removed])
ISSN: 2771-8085
To unsubscribe to this publication, go to: [link removed]
==============================================
Unsubscribe [email protected] from this list:
[link removed]
[link removed]
[link removed]
[link removed] [link removed]
Email not displaying correctly? View it in your browser ([link removed]).
[link removed]
Issue 1,687: April 12, 2023
Top Stories
* Immunize.org updates its "Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools"
* Celebrate National Adult Hepatitis B Vaccination Awareness Day, April 30, with the Hepatitis B Foundation’s resources and social media toolkit
* National Infant Immunization Week is April 24–30; use CDC’s digital media toolkit
* April is National Minority Health Month; Immunize.org supports better health through better understanding with our broad array of translated materials
* Spotlight: Immunize.org's "Handouts" main page provides free access to hundreds of vaccination-related handouts and fact sheets
* Vaccines in the news
Immunize.org Pages and Handouts
* Immunize.org updates “Administering Vaccines: Dose, Route, Site, and Needle Size” print-ready documents
* Immunize.org updates two documents for healthcare providers on injecting intramuscular and subcutaneous vaccines
* Immunize.org updates parent handout titled “Top Ten Reasons to Protect Your Child by Vaccinating”
* Immunize.org updates “Talking about Vaccines: Religious Concerns” web page
* Immunize.org updates its “Vaccine Timeline” web page
Featured Resources
* Improve uptake of HPV vaccine with the Society for Women's Health Research social media toolkit
* NFID posts new podcast episode featuring Julie L. Gerberding, MD, MPH, on breaking the cycle of crisis to complacency
* While supplies last! Laminated versions of CDC’s 2023 immunization schedules now shipping.
Notable Publications
* “Widespread Community Transmission of Hepatitis A following an Outbreak at a Local Restaurant—Virginia, September 2021–September 2022” published in MMWR
* “Seasonality of Respiratory Syncytial Virus—United States, 2017–2023” published in MMWR
Global News
* “Update on Vaccine-Derived Poliovirus Outbreaks Worldwide—January 2021–December 2022” published in MMWR
Upcoming Events
* Virtual: NFID hosts “2023 Annual Conference on Vaccinology Research” on June 5–7; registration is open; CME available
------------------------------------------------------------
Top Stories
------------------------------------------------------------
Immunize.org updates its "Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools"
Immunize.org reviews and updates the Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) every month, prominently indicating when it was last updated at the top of the page. This month’s update reflects CDC’s new recommendation for booster doses for children age 6 months through 4 years who received Pfizer-BioNTech monovalent vaccines as the 3-dose primary series. Children in this age group who received a Pfizer-BioNTech bivalent vaccine as the third dose of the primary series are still not recommended to receive a booster dose.
All COVID-19 vaccination providers should review the checklist regularly. The checklist is posted on Immunize.org's Vaccines: COVID-19 ([link removed]) main page, to help practices stay up to date.
Related Links
* Immunize.org: Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) (PDF)
* Immunize.org: Vaccines: COVID-19 ([link removed]) main page
* Immunize.org: Ask the Experts: COVID-19 ([link removed]) web page
* CDC: Interim Clinical Considerations ([link removed]) main page summarizing use of COVID-19 vaccines in the United States
------------------------------------------------------------
Celebrate National Adult Hepatitis B Vaccination Awareness Day, April 30, with the Hepatitis B Foundation’s resources and social media toolkit
Anyone can be infected with hepatitis B and all adults can benefit from knowing their status and being protected. April 30 is National Adult Hepatitis B Vaccination Awareness Day ([link removed])—a great time to make sure your patients know they need to be protected from the world's leading cause of liver cancer. The hepatitis B vaccine is now routinely recommended for adults age 19–59, yet 70% of adults have not completed the series. Adults age 60 and older also may be vaccinated.
The Hepatitis B Foundation ([link removed]) offers a social media toolkit ([link removed]) featuring graphics and sample posts. The toolkit includes a Call to Action ([link removed]) to eliminate hepatitis B through universal adult hepatitis B screening and vaccination.
Related Links
* CDC: Viral Hepatitis ([link removed]) web page
* Hepatitis B Foundation: National Adult Hepatitis B Vaccination Awareness 2023 ([link removed]) resources
* Immunize.org: Vaccines: Hepatitis B ([link removed]) main page
------------------------------------------------------------
National Infant Immunization Week is April 24–30; use CDC’s digital media toolkit
National Infant Immunization Week ([link removed]) (NIIW), April 24–30, highlights the importance of protecting infants from vaccine-preventable diseases and celebrates the achievements of immunization partners. Completing the recommended vaccinations by age 2 years is the best way to protect young children from 15 potentially life-threatening diseases. After the disruptions of three pandemic years, these messages are more important than ever for families to hear.
CDC makes it simple for you to participate in NIIW by using their 2023 NIIW Digital Media Toolkit ([link removed]) to plan activities. The toolkit includes updated English and Spanish logos, sample social media content, social graphics, and key messages. Please share your posts using the hashtag #ivax2protect.
Related Links
* CDC: National Infant Immunization Week ([link removed]) main page
* CDC: 2023 NIIW Digital Media Toolkit ([link removed]) main page
* Immunize.org: Parent Handouts ([link removed]) main page
------------------------------------------------------------
April is National Minority Health Month; Immunize.org supports better health through better understanding with our broad array of translated materials
April is National Minority Health Month ([link removed]) , a time to focus on the importance of reducing health disparities. This year’s theme focuses on improving health outcomes for racial and ethnic minority and American Indian/Alaska Native (AI/AN) communities by providing them with culturally and linguistically competent healthcare services, information, and resources. When patients get this type of culturally appropriate support, they are empowered to create healthier outcomes for themselves and their communities.
Immunize.org is working with partners to increase the availability of linguistically appropriate Vaccine Information Statements (VISs). During February and March, VIS translations were posted in eight languages: Bengali ([link removed]), Dari ([link removed]), Haitian Creole ([link removed]), Hmong ([link removed]), Pashto ([link removed]), Portuguese ([link removed]), Thai ([link removed]), and Ukrainian ([link removed]).
Immunize.org also provides users with access to translations of some of our most popular vaccination-related handouts and fact sheets for healthcare professionals and the public. Translations of these are available in up to eight languages: Arabic ([link removed]), Chinese ([link removed]), French ([link removed]), Korean ([link removed]), Russian ([link removed]), Spanish ([link removed]), Turkish ([link removed]), and Vietnamese ([link removed]).
Related Links
* HHS: National Minority Health Month ([link removed]) web page
* Immunize.org: Vaccine Information Statement ([link removed]) main page for VISs in 47 languages
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
* Immunize.org: Educational Materials for Patients and Staff ([link removed])—an alphabetical listing of more than 230 ready-to-print staff educational materials and patient handouts
------------------------------------------------------------
Spotlight: Immunize.org's "Handouts" main page provides free access to hundreds of vaccination-related handouts and fact sheets
Immunize.org's Handouts for Patients and Staff ([link removed]) web page leads users to hundreds of free vaccination-related patient handouts and fact sheets for healthcare professionals. All items are ready to print, copy, and distribute widely.
Visit the Handouts for Patients and Staff ([link removed]) web page to view more than 230 handouts sorted by:
* Topic ([link removed])
* Vaccine ([link removed])
* Language ([link removed])
From the main page, you can search by any of the 22 topics. Some of the most popular are:
* Administering Vaccines ([link removed])
* Parent Handouts ([link removed])
* Screening Checklists ([link removed])
* Standing Orders ([link removed])
* Temperature Logs ([link removed])
* Top Handouts ([link removed])
The right-hand side of the web page includes links to some of Immunize.org's most popular handouts, including:
* Summary of Recommendations for Children and Teens ([link removed])
* Summary of Recommendations for Adults ([link removed])
* Vaccinations for Adults—You’re Never Too Old to Get Immunized ([link removed])
* When Do Children and Teens Need Vaccinations? ([link removed])
* How to Administer Intramuscular and Subcutaneous Vaccine Injections: Administration by the Intramuscular (IM) Route ([link removed])
You can also view an alphabetical listing of Immunize.org’s more than 230 ready-to-print staff educational materials and patient handouts ([link removed]).
Visit Immunize.org's Handouts for Patients and Staff ([link removed]) web page today!
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* Bloomberg Law: Future COVID Shots Need Broader Coverage, FDA Vaccine Head Says ([link removed]) (4/4/23)
* Scripps News: What Happens to COVID Vaccines When the Public Health Emergency Ends? ([link removed]) (4/3/23)
* Precision Vaccinations: Has Polio Returned to America ([link removed]) (4/3/23)
------------------------------------------------------------
Immunize.org Pages and Handouts
------------------------------------------------------------
Immunize.org updates “Administering Vaccines: Dose, Route, Site, and Needle Size” print-ready documents
Immunize.org recently updated two of its print-ready documents: Administering Vaccines: Dose, Route, Site, and Needle Size ([link removed]) and Administering Vaccines to Adults: Dose, Route, Site, and Needle Size ([link removed]) . The documents now reflect the recent FDA approval of intramuscular (IM) administration of Merck's measles-mumps-rubella vaccine (MMR, brand name M-M-R II), varicella (Varivax), and MMRV (ProQuad) vaccines as an alternative to subcutaneous (Subcut) administration. GSK’s MMR (Priorix) remains approved for Subcut administration only.
Related Links
* Immunize.org: Handouts: Administering Vaccines ([link removed]) main page
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
* Immunize.org: Educational Materials for Patients and Staff ([link removed])—an alphabetical listing of more than 230 ready-to-print staff educational materials and patient handouts
------------------------------------------------------------
Immunize.org updates two documents for healthcare providers on injecting intramuscular and subcutaneous vaccines
Immunize.org recently updated its How to Administer Intramuscular and Subcutaneous Vaccine Injections ([link removed]) handout and How to Administer Intramuscular and Subcutaneous Vaccine Injections to Adults ([link removed]) handout. Changes include:
* Intramuscular (IM) administration of Merck's MMR (M-M-R II), varicella (Varivax), and MMRV (ProQuad) vaccines as well as the current subcutaneous (Subcut) listing. GSK's MMR (Priorix) remains Subcut only.
* Grouping vaccines into categories of IM only, IM or Subcut, Subcut only, and Subcut or intradermal routes
Related Links
* Immunize.org: Handouts: Administering Vaccines ([link removed]) main page
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
* Immunize.org: Educational Materials for Patients and Staff ([link removed])—an alphabetical listing of more than 230 ready-to-print staff educational materials and patient handouts
------------------------------------------------------------
Immunize.org updates parent handout titled “Top Ten Reasons to Protect Your Child by Vaccinating”
Immunize.org recently updated its handout for parents titled Top Ten Reasons to Protect Your Child by Vaccinating ([link removed]). Minor changes were made to the text to enhance comprehension. A QR code in the footer now links to the online version of the document.
Related Links
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
* Immunize.org: Educational Materials for Patients and Staff ([link removed])—an alphabetical listing of more than 230 ready-to-print staff educational materials and patient handouts
------------------------------------------------------------
Immunize.org updates “Talking about Vaccines: Religious Concerns” web page
Immunize.org updated its Talking about Vaccines: Religious Concerns ([link removed]) main page. This page leads to many resources from Immunize.org, CDC, and others to help healthcare professionals communicate with parents and patients about important vaccine topics. Additions are described below.
* Added the Statement on COVID-19 Vaccines from the Orthodox Union and Rabbinical Council of America ([link removed]) from the Orthodox Union (OU) and the Rabbinical Council of America (RCA)
* Added Address Concerns About Religious Beliefs ([link removed]) from the American Pharmacists Association Vaccine Confident Initiative
Related Link
* Immunize.org: Talking about Vaccines ([link removed]) main page
------------------------------------------------------------
Immunize.org updates its “Vaccine Timeline” web page
Immunize.org's Vaccine Timeline ([link removed]) main page was updated on April 4 to include new events related to vaccines and immunization. The chart on the main page displays many of the vaccine- and immunization-related events since Edward Jenner's first smallpox vaccination in 1796. This list is by no means exhaustive.
If you would like to suggest an event to add, contact us at [email protected].
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
Improve uptake of HPV vaccine with the Society for Women's Health Research social media toolkit
April is Sexually Transmitted Infections Awareness Month. The Society for Women's Health Research (SWHR) offers resources to improve education ([link removed]) on human papillomavirus (HPV) vaccine and its crucial role in public health.
Check out the HPV Vaccine Social Media Toolkit ([link removed]) today and follow the HPV vaccine conversation at #SWHRtalksHPV and on all SWHR social channels.
------------------------------------------------------------
NFID posts new podcast episode featuring Julie L. Gerberding, MD, MPH, on breaking the cycle of crisis to complacency
Infectious IDeas ([link removed]), a podcast series from the National Foundation for Infectious Diseases (NFID), brings leading experts together for thought-provoking conversations that lead to infectious ideas. The latest entry in the series, Breaking the Cycle of Crisis to Complacency ([link removed]), features Julie L. Gerberding, MD, MPH. A description from the web page appears below.
As the first female director of the Centers for Disease Control and Prevention (CDC), Julie L. Gerberding, MD, MPH, led the agency through 40 public health crises, including SARS-CoV-1. As CEO of the Foundation for the National Institutes of Health, she now advocates for change to strengthen US health security and break the cycle of crisis to complacency.
------------------------------------------------------------
While supplies last! Laminated versions of CDC’s 2023 immunization schedules now shipping.
Immunize.org's laminated versions of the 2023 U.S. child and adolescent immunization schedule ([link removed]) and the 2023 U.S. adult immunization schedule ([link removed]) are in stock and shipping now. Order while supplies last. Once sold out, we will not print more until 2024.
While the schedules are available online from CDC at no cost, Immunize.org’s laminated schedules are ideal for use in any busy healthcare setting. Their tough coating can be wiped down, and they’re durable enough to stand up to a year of use.
* Length: Each schedule with appendices is 12 pages
* Size: Standard 8.5” X 11” booklet format
* Full Color: With color coding for easy reading, our laminated schedules replicate the original CDC formatting, including the essential tables and notes
* Bonus: The adult schedule includes Immunize.org’s popular 1-page handout summarizing the dose, route, and needle length recommendations for all vaccines and recipients
Pricing for Each Schedule
$10.00: 1 copy
$ 9.50 each: 2–4 copies
$ 8.50 each: 5–19 copies
$ 7.50 each: 20–99 copies
$ 6.00 each: 100–499 copies
$ 5.00 each: 500–999 copies
$ 4.00 each: 1,000–1,999 copies
$ 3.25 each: 2,000+ copies
Visit Shop Immunize.org: Laminated Schedules ([link removed]) to view images of each page and order today!
For additional information, call 651-647-9009 or email [email protected].
Related Links
* Immunize.org: Laminated Child and Adolescent Immunization Schedules (0–18 years) ([link removed]) web page
* Immunize.org: Laminated Adult Immunization Schedules (19 and older) ([link removed]) web page
* Immunize.org: Shop Immunize.org ([link removed]) main page
* CDC: Immunization Schedules ([link removed])
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
“Widespread Community Transmission of Hepatitis A following an Outbreak at a Local Restaurant—Virginia, September 2021–September 2022” published in MMWR
CDC published Widespread Community Transmission of Hepatitis A Virus following an Outbreak at a Local Restaurant—Virginia, September 2021–September 2022 ([link removed]) in the April 7 issue of MMWR ([link removed]). A portion of the summary appears below.
In 2021, a hepatitis A outbreak in Virginia traced to an unvaccinated food handler resulted in 51 cases, 31 hospitalizations, and three deaths. As of September 30, 2022, an additional 98 community hepatitis A cases had been reported in the Roanoke City and Alleghany Health Districts. . . .
Public health partnerships with businesses and other community partners (e.g., harm reduction programs) might increase hepatitis A vaccination among persons at risk for this infection, while also reducing the stigmatization of hepatitis A-associated risk factors.
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]) .
Related Link
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications
------------------------------------------------------------
“Seasonality of Respiratory Syncytial Virus—United States, 2017–2023” published in MMWR
CDC published Seasonality of Respiratory Syncytial Virus—United States, 2017–2023 ([link removed]) in the April 7 issue of MMWR ([link removed]).
The article explains that, nationally, prepandemic seasons (2017– 2020) began in October, peaked in December, and ended in April. During 2020–21, the typical winter RSV epidemic did not occur. The 2021–22 season began in May, peaked in July, and ended in January. The 2022–23 season started (June) and peaked (November) later than the 2021–22 season, but earlier than prepandemic seasons. In both prepandemic and pandemic periods, epidemics began earlier in Florida and the Southeast and later in regions further north and west.
With several RSV prevention products in development, ongoing monitoring of RSV circulation can guide the timing of RSV immunoprophylaxis and of clinical trials and postlicensure effectiveness studies. Although the timing of the 2022–23 season suggests that seasonal patterns are returning toward those observed in prepandemic years, clinicians should be aware that off-season RSV circulation might continue.
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]).
Related Link
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications
------------------------------------------------------------
Global News
------------------------------------------------------------
“Update on Vaccine-Derived Poliovirus Outbreaks Worldwide—January 2021–December 2022” published in MMWR
CDC published Update on Vaccine-Derived Poliovirus Outbreaks Worldwide—January 2021–December 2022 ([link removed]) in the April 7 issue of MMWR ([link removed]). A portion of the summary appears below.
During January 2021–December 2022, 76 [circulating vaccine-derived polioviruses] cVDPV type 2 outbreaks occurred in 42 countries. Since 2020, the numbers of paralytic cases and new emergences have declined following the introduction of a safer novel type 2 oral poliovirus vaccine for outbreak control. The number of cVDPV type 1 outbreaks increased during 2021–2022 as COVID-19 pandemic–associated global routine immunization coverage declined. . . .
Improving routine immunization coverage, strengthening poliovirus surveillance, and conducting timely and high-quality supplementary immunization activity responses to cVDPV outbreaks in 2023 are necessary to stop cVDPV transmission.
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]).
Related Link
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Virtual: NFID hosts “2023 Annual Conference on Vaccinology Research” on June 5–7; registration is open; CME available
The National Foundation for Infectious Diseases (NFID) will host its 2023 Annual Conference on Vaccinology Research ([link removed]) (ACVR) on June 5–7. Learn and network with hundreds of researchers and healthcare professionals from around the world. The conference will feature informative presentations with interactive audience discussions, peer-reviewed oral and poster abstracts, and an inspiring session spotlighting women leaders in vaccinology.
Registration is now open ([link removed]) and there is a $400 fee to attend. NFID will offer CME for the live activity. Visit the ACVR website ([link removed]) for updates and additional information.
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]).
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles. When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]).
IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer ([link removed])
ISSN: 2771-8085
To unsubscribe to this publication, go to: [link removed]
==============================================
Unsubscribe [email protected] from this list:
[link removed]
Message Analysis
- Sender: Immunization Action Coalition
- Political Party: n/a
- Country: United States
- State/Locality: n/a
- Office: n/a
-
Email Providers:
- MailChimp